World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
44381
World Ranking
8477
National Ranking
4378

Overview

Joseph A. Sparano is affiliated with Albert Einstein College of Medicine in the United States. Their research focuses primarily on medicine and biochemistry, genetics, and molecular biology, with a notable emphasis on oncology and cancer research.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their specific subfields of study cover:

  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Genetics
  • Radiology, Nuclear Medicine and Imaging

Joseph A. Sparano's work extensively addresses the following main topics:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening

Several recent papers show the range and impact of their scholarly contributions. These publications include:

  • Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System, 2020, published in Cancer Discovery
  • Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2023, published in Annals of Oncology
  • Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer, 2022, published in New England Journal of Medicine
  • Seroconversion rates following COVID-19 vaccination among patients with cancer, 2021, published in Cancer Cell
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, published in The Lancet Oncology

The scientist frequently collaborates with colleagues including Lynne I. Wagner, Robert J. Gray, Della Makower, Kathy D. Miller, and Ruth C. Carlos.

Joseph A. Sparano has published numerous articles in prominent journals. The venues where they publish most often are:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • npj Breast Cancer
  • Cancer

Best Publications

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    Joseph A. Sparano;Robert J. Gray;Della F. Makower;Kathleen I. Pritchard

  • Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    Sylvia Adams;Robert J. Gray;Sandra Demaria;Lori Goldstein

  • Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard

  • Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    Joseph A. Sparano;Joseph A. Sparano;Molin Wang;Silvana Martino;Vicky Jones

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

    Clifford A. Hudis;William E. Barlow;Joseph P. Costantino;Robert J. Gray

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.

    Vikas Mehta;Sanjay Goel;Rafi Kabarriti;Daniel Cole

  • Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

    Joseph A. Sparano;Soonmyung Paik

  • A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

    Lawrence J. Solin;Robert Gray;Robert Gray;Frederick L. Baehner;Steven M. Butler

  • Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

    Lawrence D. Kaplan;Jeannette Y. Lee;Richard F. Ambinder;Joseph A. Sparano

  • Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life

    Alyson B. Moadel;Chirag Shah;Judith Wylie-Rosett;Melanie S. Harris

  • Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

    Joseph A. Sparano;Robert J. Gray;Peter M. Ravdin;Della F. Makower;Della F. Makower

  • Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

    George S. Karagiannis;Jessica M. Pastoriza;Yarong Wang;Allison S. Harney

  • Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    Sara A. Hurvitz;Miguel Martin;W. Fraser Symmans;Kyung Hae Jung

  • Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

    Lori J. Goldstein;Robert Gray;Sunil Badve;Barrett H. Childs

  • Progress in adjuvant chemotherapy for breast cancer: an overview

    Jesus Anampa;Della Makower;Joseph A. Sparano

Frequent Co-Authors

George W. Sledge
George W. Sledge Stanford University
Nancy E. Davidson
Nancy E. Davidson University of Washington
Kathy D. Miller
Kathy D. Miller Indiana University
Sunil Badve
Sunil Badve Emory University
William C. Wood
William C. Wood Emory University
Jeannette Y. Lee
Jeannette Y. Lee University of Arkansas for Medical Sciences
Edith A. Perez
Edith A. Perez Mayo Clinic
Timothy J. Whelan
Timothy J. Whelan McMaster University
Ronald T. Mitsuyasu
Ronald T. Mitsuyasu University of California, Los Angeles
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternatives to traditional medical school, there are several respected online degree options and career pathways. Leadership roles in hospitals and clinics are growing, and an online master of health administration can prepare you for high-level administrative positions while allowing flexible study schedules.

Cost is a key concern for many students. Fortunately, there are affordable mha online programs available that help reduce student debt while still providing rigorous training in healthcare policy, management, and leadership.

Nursing professionals looking to advance their clinical expertise may want to consider the cheapest bsn to dnp programs. These Doctor of Nursing Practice programs offer an affordable pathway to becoming a leader in nursing practice or health systems.

Pharmacy is another essential healthcare field that can also be pursued online. A pharmacy degree online provides a flexible option for aspiring pharmacists seeking a career in clinical, research, or community pharmacy settings.

Best Scientists Citing Joseph A. Sparano

Trending Scientists

Recently Published Articles